Quick Order Cart

Cat. No. ARG32749

KIAA0319L Knockout SK-HEP-1 Polyclonal Cells

  • Product Type:

    Polyclonal Cell Population

  • Species:

    Homo sapiens (Human)

  • Tissue Source:

    Liver

  • Disease:

    Adenocarcinoma

KIAA0319L Knockout SK-HEP-1 Polyclonal Cells consist of a CRISPR/Cas9-edited polyclonal knockout cell population derived from the SK-HEP-1 human hepatic endothelial cell line, with disrupted KIAA0319L expression. SK-HEP-1 cells exhibit hallmark liver sinusoidal endothelial features, including von Willebrand factor (vWF) and CD31 expression, and are widely used to study scavenging, filtration, and angiogenesis. KIAA0319L is a transmembrane receptor containing an extracellular PKD domain that interacts with clathrin and the AP-2 subunit AP2M1 to regulate clathrin-mediated endocytosis and ciliary assembly. Applications of this knockout model include endocytosis assays, endothelial migration studies, ciliopathy modeling, and protein interaction analyses, leveraging techniques such as transferrin uptake, Western blot, and co-immunoprecipitation.

Inquire Now

In stock

Ships next business day


Ask a Question

Shipping Info:

Cryopreserved in vials and shipped on dry ice


Disclaimer:

For Research Use Only

  • Characteristics

    Host Cell

    SK-HEP-1

    Sex of Donor

    Male

    Age

    52 years

    Gene Name

    KIAA0319L

    Gene Identifier

    NCBI Gene ID 79932

    Morphology

    Epithelial-like

    Growth Mode

    Adherent

    Storage

    Liquid nitrogen (LN2)

  • Culture Conditions

    Growth medium

    MEM (with NEAA)

    Supplement(s)

    10% Fetal Bovine Serum, 1% Penicillin-Streptomycin Solution

    Temperature

    37°C

    Atmosphere

    5% CO₂

  • Quality Control

    Sterility testing

    The bacterial, yeast, and fungi are not detected in these cells by daily monitor.

    Mycoplasma testing

    Negative for mycoplasma through PCR analysis

  • Disclaimer

    Intended Use

    This product is intended for laboratory in vitro use only. lt is not intended for diagnostic, therapeutic, or clinical applications.

    Disclaimer

    Ascent Research endeavors to provide accurate and up-to-date product information. However, no warranties or representations are made regarding its completeness or reliability. References to scientific literature and patents are for informational purposes only, and the customer assumes sole responsibility for verifying their accuracy.

    By accepting this product, the customer acknowledges and agrees to assume all risks associated with its receipt, handling, storage, disposal, and use, including compliance with all applicable safety and environmental regulations and precautions. Relevant laws, regulations, and ethical guidelines must be followed in conducting any research, modifications, or derivatives derived from this product.

    This product is provided "AS IS", and except as expressly stated herein, Ascent Research disclaims all other warranties, express or implied. Under no circumstances shall Ascent Research, its affiliates, or representatives be liable for indirect, incidental, consequential, or punitive damages arising from the use of this material. While Ascent Research employs rigorous quality control measures, we shall not be held responsible for damages resulting from misidentification or misinterpretation of the provided materials.

Description

The KIAA0319L Knockout SK-HEP-1 Polyclonal Cells comprise a CRISPR/Cas9-edited polyclonal knockout cell population derived from the human SK-HEP-1 cell line, featuring disruption of the KIAA0319L gene. This loss-of-function model enables systematic exploration of KIAA0319L-dependent mechanisms within an endothelial background, avoiding clonal bias via a heterogeneous polyclonal pool. The CRISPR/Cas9-mediated gene ablation provides a stable in vitro platform for studying endocytosis and migration-related processes, supporting pooled population analyses.

SK-HEP-1 cells are a human hepatic adenocarcinoma line with well-characterized endothelial attributes, including von Willebrand factor (vWF) expression, CD31 positivity, and robust low-density lipoprotein (LDL) uptake. Widely employed as a liver sinusoidal endothelial cell (LSEC) model, these cells replicate key LSEC activities such as macromolecule filtration, scavenging, immune surveillance, and angiogenesis. This cellular context allows dissection of KIAA0319L function in vascular cell biology, extending its significance beyond neuronal systems.

KIAA0319L is a type I transmembrane protein possessing an extracellular PKD domain that facilitates cell-cell and cell-matrix adhesion. The protein interacts with clathrin, the AP-2 complex adaptor subunit AP2M1, and the related KIAA0319 protein, positioning it within the clathrin-mediated endocytosis machinery. Downstream, dynamin-mediated membrane scission completes endocytic vesicle formation, linking KIAA0319L to cytoskeletal reorganization and ciliogenic pathways. In endothelial cells, KIAA0319L-mediated endocytosis may govern receptor internalization and signal transduction necessary for migration and barrier function.

Loss of KIAA0319L in SK-HEP-1 cells disrupts clathrin-dependent trafficking, potentially impairing scavenger function and angiogenic responses. Given the gene??s role in ciliary assembly, this knockout model may unveil contributions of ciliated endothelial signaling to vascular homeostasis or disease. By studying KIAA0319L in an LSEC mimic, researchers can investigate how endocytic receptors regulate endothelial migration and the cellular response to shear stress or injury.

This polyclonal knockout product is suited for transferrin uptake assays to quantify endocytosis, wound-healing migration assays to assess motility, and ciliogenesis analyses. Co-immunoprecipitation with AP2M1 or clathrin verification supports interaction studies, while RNA-seq and immunofluorescence enable global expression profiling and subcellular localization. Applications include functional genomics of endothelial endocytosis, ciliopathy modeling, and migration research. For inquiries, please contact Ascent Research.

Reset Password

    Reach Us Questions? Click Me Here!

    Fill out the form below and a member of our team will contact you shortly!

    *Required field



      Reach Us

      Fill out the form below and a member of our team will contact you shortly!

      *Required field

      Product Inquiry (Optional)